LEXX
Lexaria Bioscience Corp.
There isn't enough reported data to score LEXX yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
LEXX Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Unavailable |
LEXX's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
LEXX PE Valuation
LEXX has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
LEXX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect LEXX's losses to grow, with revenue holding steady.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
LEXX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$5.25 | +$5.46 |
| Q1 2026 | -$7.20 | +$2.05 |
| Q4 2025 | -$8.55 | -$0.80 |
| Q3 2025 | -$9.90 | -$2.85 |
| Q2 2025 | -$10.71 | -$4.77 |
| Q1 2025 | -$9.25 | -$0.60 |
| Q4 2024 | -$7.75 | +$3.39 |
| Q3 2024 | -$7.05 | +$6.83 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 149% for LEXX versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
LEXX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $20K | -89% |
| Q3 2025 | $174K | +107% |
| Q2 2025 | $174K | +107% |
| Q1 2025 | $174K | +20% |
| Q4 2024 | $183.9K | +22% |
| Q2 2024 | $84K | -9.8% |
| Q1 2024 | $145K | +314% |
| Q4 2023 | $151.3K | +49% |
UNH has the stronger quarterly revenue trend. Revenue is down 100% for LEXX versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -7260% | -5679 points |
| Q3 2025 | -1545% | +1078 points |
| Q2 2025 | -2155% | -81 points |
| Q1 2025 | -1581% | -1120 points |
| Q4 2024 | -1463% | -710 points |
| Q3 2024 | -2623% | N/A |
| Q2 2024 | -2075% | N/A |
| Q1 2024 | -461% | N/A |
LEXX's operating margin was −7260% last quarter, down 5797 points from the same quarter a year ago, near the bottom of its range since 2022.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
LEXX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.6M | +$1.9M |
| Q1 2026 | -$2.2M | -$706.8K |
| Q4 2025 | -$984.1K | +$1.8M |
| Q3 2025 | -$2.6M | -$707.8K |
| Q2 2025 | -$3.6M | -$2.3M |
| Q1 2025 | -$1.5M | -$878.3K |
| Q4 2024 | -$2.8M | -$1.6M |
| Q3 2024 | -$1.9M | -$244.6K |
UNH has the stronger cash trend. Its trailing FCF is up 5.2% versus its history, compared with LEXX at down 26%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
LEXX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +24.1K shares |
| 1 year | +36% | +434K shares |
| 3 years | +314% | +1.3M shares |
| 5 years | +726% | +1.5M shares |
| Available history | +857% | +1.5M shares |
LEXX has 2M diluted shares, up 36% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2023 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over LEXX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
LEXX Net Leverage
LEXX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
LEXX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.6 | Neutral |
| Stochastic | 13.6 | Oversold |
LEXX's weekly RSI is 43 (neutral) and its Stochastic is 14 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
LEXX PE vs Healthcare Sector
LEXX has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
LEXX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.45 | 21% above |
| 20 week MA | $6.32 | 34% below |
| 50 week MA | $9.25 | 55% below |
| 100 week MA | $14.0 | 70% below |
| 200 week MA | $23.3 | 82% below |
LEXX has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 82% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over LEXX on trend strength, trading above more of its moving averages.
LEXX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $68.7 | $62.9 | -8.5% |
| 2022 | $62.9 | $36.8 | -42% |
| 2023 | $36.8 | $18.8 | -49% |
| 2024 | $18.8 | $34.4 | +83% |
| 2025 | $34.4 | $7.96 | -77% |
| 2026 YTD | $7.96 | $4.18 | -47% |
LEXX has finished lower in four of the last five years. It's down 47% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over LEXX on returns for 2026, with the stronger performance.